$558 Million is the total value of Wildcat Capital Management, LLC's 20 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KITE | KITE PHARMA INC | $433,348,000 | +73.4% | 2,410,034 | 0.0% | 77.71% | +17.0% | |
| CSGP | Sell | COSTAR GROUP INC | $47,434,000 | -1.0% | 176,827 | -2.7% | 8.51% | -33.2% |
| NK | NANTKWEST INC | $18,586,000 | -27.8% | 3,391,539 | 0.0% | 3.33% | -51.3% | |
| LPLA | LPL FINANCIAL HOLDINGS INC | $10,693,000 | +21.5% | 208,401 | 0.0% | 1.92% | -18.0% | |
| EMB | ISHARES JP MORGAN USD EMERGIjp mor em mk etf | $8,087,000 | +1.8% | 70,000 | 0.0% | 1.45% | -31.3% | |
| SBR | Buy | SABINE ROYALTY TRUSTunit ben int | $7,533,000 | +163.5% | 186,000 | +149.6% | 1.35% | +77.8% |
| CSAL | New | UNITI GROUP INC | $6,021,000 | – | 410,700 | +100.0% | 1.08% | – |
| MDXG | New | MIMEDX GROUP INC | $5,940,000 | – | 500,000 | +100.0% | 1.06% | – |
| SRNE | SORRENTO THERAPEUTICS INC | $4,760,000 | -15.0% | 2,799,790 | 0.0% | 0.85% | -42.6% | |
| URGN | UROGEN PHARMA LTD | $4,255,000 | +74.5% | 135,000 | 0.0% | 0.76% | +17.7% | |
| PLAY | New | DAVE & BUSTER'S ENTERTAINMEN | $3,149,000 | – | 60,000 | +100.0% | 0.56% | – |
| PLYA | PLAYA HOTELS & RESORTS NV | $3,129,000 | -12.7% | 300,000 | 0.0% | 0.56% | -41.1% | |
| FXY | CURRENCYSHARES JAPANESE YENjapanese yen | $2,667,000 | -0.2% | 31,245 | 0.0% | 0.48% | -32.7% | |
| EDIT | EDITAS MEDICINE INC | $992,000 | +43.1% | 41,324 | 0.0% | 0.18% | -3.3% | |
| NH | NANTHEALTH INC | $984,000 | -2.6% | 238,828 | 0.0% | 0.18% | -34.6% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $55,000 | +44.7% | 15,000 | 0.0% | 0.01% | 0.0% | |
| Exit | POWERSHS DB MULTI SECT COMMcall | $0 | – | -29,400 | -100.0% | -0.19% | – | |
| Exit | CURRENCYSHARES EURO TRput | $0 | – | -9,023 | -100.0% | -0.26% | – | |
| BABA | Exit | ALIBABA GROUP HLDG LTDsponsored ads | $0 | – | -20,068 | -100.0% | -0.75% | – |
| Exit | MIMEDX GROUP INCcall | $0 | – | -391,000 | -100.0% | -1.56% | – | |
| UNIT | Exit | UNITI GROUP INC | $0 | – | -263,000 | -100.0% | -1.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COSTAR GROUP INC | 32 | Q3 2022 | 48.3% |
| UROGEN PHARMA LTD | 26 | Q3 2023 | 17.3% |
| META PLATFORMS INC | 26 | Q3 2023 | 9.9% |
| ALLOGENE THERAPEUTICS INC | 18 | Q3 2023 | 22.4% |
| GOOSEHEAD INSURANCE INC -A | 18 | Q3 2023 | 15.4% |
| SABINE RTY TRUST | 18 | Q3 2021 | 11.3% |
| LPL FINL HLDGS INC | 18 | Q1 2019 | 12.7% |
| PLAYA HOTELS & RESORTS NV | 18 | Q3 2021 | 3.4% |
| NANTKWEST INC | 17 | Q3 2019 | 22.0% |
| SORRENTO THERAPEUTICS INC | 17 | Q2 2019 | 7.0% |
View Wildcat Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Skillz Inc. | January 05, 2023 | 19,596,988 | 5.6% |
| UroGen Pharma Ltd. | February 14, 2022 | 533,139 | 2.4% |
| Skillz Inc. | March 08, 2021 | 21,832,022 | 7.5% |
| NantKwest, Inc. | February 13, 2018 | 808,974 | 1.0% |
| Sorrento Therapeutics, Inc. | February 13, 2018 | 1,738,232 | 2.2% |
View Wildcat Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-04-08 |
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-09 |
| PX14A6G | 2023-11-03 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-07 |
| SC 13D/A | 2023-01-05 |
View Wildcat Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.